Kamboj's doctoral thesis was about Biochemical Studies on pollen and pollen-pistil interaction in `Petunia hybrida`.
Thereafter, he moved to Canada to join Allelix Biopharmaceuticals Inc (a part of NPS Pharmaceuticals, Inc, Toronto), as its Vice President and Chief Scientific Officer.
After working about 12 years with Allelix, Dr Kamboj joined Xenon Genetics Inc, Vancouver as its vice president for Drug Discovery.
He holds over forty (40) U.S. patent applications (filed and issued), covering the discovery and use of a number of human genes.
Dr Kamboj is also a member of the Market Advisory Groups (MAG) of the Asia Pacific Trade Council of British Columbia, Canada.